Magnetic resonance spectroscopy to measure hepatic triglyceride content: prevalence of hepatic steatosis in the general population. - Wikidata - awgldk - TriplyDB

Magnetic resonance spectroscopy to measure hepatic triglyceride content: prevalence of hepatic steatosis in the general population.

Magnetic resonance spectroscopy to measure hepatic triglyceride content: prevalence of hepatic steatosis in the general population.

http://www.wikidata.org/entity/Q39693472

about

Circulating fibroblast growth factor 21 levels are closely associated with hepatic fat content: a cross-sectional study Ectopic fat and insulin resistance: pathophysiology and effect of diet and lifestyle interventions Nonalcoholic fatty liver disease: an emerging threat to obese and diabetic individuals Non-alcoholic fatty liver disease: what the clinician needs to know.Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: Selected practical issues in their evaluation and management Association between white blood cell count and non-alcoholic fatty liver disease in urban Han Chinese: a prospective cohort study Non-invasive Markers of Liver Fibrosis: Adjuncts or Alternatives to Liver Biopsy?Hypoxia-inducible factors as molecular targets for liver diseases A Comprehensive Updated Review of Pharmaceutical and Nonpharmaceutical Treatment for NAFLD Non-Alcoholic Steatohepatitis: Limited Available Treatment Options but Promising Drugs in Development and Recent Progress Towards a Regulatory Approval Pathway Nonalcoholic Fatty liver disease and risk of diabetes and cardiovascular disease: what is important for primary care physicians?Carbohydrate intake and nonalcoholic fatty liver disease: fructose as a weapon of mass destruction Diagnosis and management of non-alcoholic fatty liver disease and related metabolic disorders: consensus statement from the Study Group of Liver and Metabolism, Chinese Society of Endocrinology Proprotein convertase subtilisin/kexin type 9: from the discovery to the development of new therapies for cardiovascular diseases Effects of lixisenatide on elevated liver transaminases: systematic review with individual patient data meta-analysis of randomised controlled trials on patients with type 2 diabetes Role of mitochondria in nonalcoholic fatty liver disease Efficacy of Berberine in Patients with Non-Alcoholic Fatty Liver Disease Hepatitis C virus-infected patients are 'spared' from the metabolic syndrome but not from insulin resistance. A comparative study of nonalcoholic fatty liver disease and hepatitis C virus-related steatosis Definitions of Normal Liver Fat and the Association of Insulin Sensitivity with Acquired and Genetic NAFLD-A Systematic Review The Flexibility of Ectopic Lipids Hepatic steatosis and fibrosis: Non-invasive assessment.Farnesoid X receptor: a master regulator of hepatic triglyceride and glucose homeostasis YKL-40 is a Protective Biomarker for Fatty Liver in World Trade Center Particulate Matter-Exposed Firefighters Association of liver enzymes and computed tomography markers of liver steatosis with familial longevity Triglycerides in the human kidney cortex: relationship with body size Small molecule glucokinase activators disturb lipid homeostasis and induce fatty liver in rodents: a warning for therapeutic applications in humans Accuracy of Liver Fat Quantification With Advanced CT, MRI, and Ultrasound Techniques: Prospective Comparison With MR Spectroscopy Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease Perspectives on Nonalcoholic Fatty Liver Disease: An Overview of Present and Future Therapies Impact of anthropometric cut-off values in determining the prevalence of metabolic alterations.Choline Supplementation With a Structured Lipid in Children With Cystic Fibrosis: A Randomized Placebo-Controlled Trial Imaging methods for analyzing body composition in human obesity and cardiometabolic disease.The Riddle of Nonalcoholic Fatty Liver Disease: Progression From Nonalcoholic Fatty Liver to Nonalcoholic Steatohepatitis.Review of clinical studies of Polygonum multiflorum Thunb. and its isolated bioactive compounds Metformin use in children with obesity and normal glucose tolerance--effects on cardiovascular markers and intrahepatic fat.Importance of imaging and recent developments in diagnosis of nonalcoholic fatty liver disease.Ultrasound hepatic/renal ratio and hepatic attenuation rate for quantifying liver fat content.Predicting total, abdominal, visceral and hepatic adiposity with circulating biomarkers in Caucasian and Japanese American women.Radiologic evaluation of nonalcoholic fatty liver disease Alterations in ventricular structure and function in obese adolescents with nonalcoholic fatty liver disease.

P2860

Q21135215-F2F0DA3C-25D6-4DCB-8CA2-417D8C65F4D0 Q21285128-A13D07B6-3069-46E1-A25F-856CA6948168 Q22299426-9D1D6844-6EE7-4EC4-86E7-65D6DA4D491E Q24563068-DF65E0AE-082F-4FFE-A861-956E39E41107 Q24649618-274F957E-4B73-4937-8C4A-BE2BDFDDE6A6 Q24658538-1B8A7635-60E3-484C-A0B1-FB1B0EA6115A Q26744631-BEA249D3-AC7F-4BB1-883C-71BD2CBA9BBC Q26752304-B5037969-6F91-4FA4-9D1C-B277E8075850 Q26752487-0D461714-FD97-4F34-9C9E-F05D0AAC78A2 Q26800894-E9880EBE-FDF1-4C50-ABCE-BD0B9CF3EFC1 Q26827169-867846C2-2FEB-4FBE-891B-81B850D4DEEA Q26991952-9D93C418-9D2C-426B-930B-D12397E6F25A Q26998471-0541BC15-7D3D-4A7F-A35B-6C2DD6F81DFE Q27009477-FDE2552E-78D7-4D85-A5BC-DC7FDFCA39D8 Q27025423-1526B619-BE06-4F57-BF9E-37DA19E2C76D Q27028142-AA4EBEC7-28CD-489E-8DD0-C07F3791FE13 Q27301440-6760154F-A431-42D0-869E-E277F4017642 Q27488919-A3D70C58-2917-4B06-818E-37AC52546470 Q28070408-7403F374-CE36-4810-921D-A666430CEDC7 Q28076063-BFA44A70-3060-40F1-9040-7638BCBC9F5B Q28077200-3D58E2D4-3917-4F1A-B26C-B7294E7F067E Q28253815-0DF0FDE5-77B7-48F7-BAE8-48E809631585 Q28388339-07CE0722-C435-4089-A2B7-57294597ED75 Q28540897-7594F747-86FB-46FD-9E17-05AC5001ADA5 Q28542644-94C12BCA-5FD7-4015-A35E-116830282C5E Q28576077-745B55C9-9C91-4615-A2D1-D3F514C463A6 Q28818256-BCA168B0-07C9-4EEF-9712-76443E1323A6 Q29614897-E0CF1738-318C-450A-96D4-AA6A9ABA0989 Q30234444-4D0D0B53-E5E9-445F-AADA-5D6A52316961 Q30244063-1F667E55-606E-494D-9AF8-9D5C78AEDE92 Q30278529-F4C75332-05D2-41E8-A7F9-E18442068B1F Q30377639-3F2945BB-42DE-4851-AA30-C6BE2E96D9CF Q30382395-A5DF6263-4295-4523-8776-54DE63A7304B Q30408018-E21F367D-D977-437F-8163-115C1FD6F9DA Q30413605-87B81711-23CF-4B18-B545-030D0A593228 Q30413672-CBA9D5A1-C566-40A1-B80A-51D9566AFBC3 Q30422374-BEE5691F-EDB2-43EC-BF0D-227CBCA1CE50 Q30425474-7E59874C-CB37-431D-86C5-251CE940E40D Q30436162-CD13B12B-659B-42D3-B9EB-9511AA94834D Q30437623-FD718ADB-B1C1-4C59-9F11-E970C34E67B5

P2860

Magnetic resonance spectroscopy to measure hepatic triglyceride content: prevalence of hepatic steatosis in the general population.

http://www.wikidata.org/entity/Q39693472

description

2004 nî lūn-bûn

@nan

2004年の論文

@ja

2004年論文

@yue

2004年論文

@zh-hant

2004年論文

@zh-hk

2004年論文

@zh-mo

2004年論文

@zh-tw

2004年论文

@wuu

2004年论文

@zh

2004年论文

@zh-cn

name

Magnetic resonance spectroscop ...... sis in the general population.

@en

Magnetic resonance spectroscop ...... sis in the general population.

@nl

type

label

Magnetic resonance spectroscop ...... sis in the general population.

@en

Magnetic resonance spectroscop ...... sis in the general population.

@nl

prefLabel

Magnetic resonance spectroscop ...... sis in the general population.

@en

Magnetic resonance spectroscop ...... sis in the general population.

@nl

P1433

Q39693472-75CC4D1D-9D4E-4217-8F04-599E40FB26D4

P1476

Q39693472-9D45D0F8-8F6F-447E-898B-4F4337B6D180

P2093

Q39693472-24B6D1AD-FCEF-4129-8CA5-36AD662C116B

Q39693472-3D8C10C5-0654-4717-88BB-384AA8D1116A

Q39693472-5E7AA5B4-77B7-4EF8-91E1-14D28B1F0C09

Q39693472-93BD3C52-64AE-47E4-AE05-28D28F359DD0

Q39693472-98A4767B-A584-47FF-9DF3-0DFAA3F0A448

Q39693472-CF1E711B-92D3-47D7-AE44-AC409108902B

Q39693472-E4EFE478-0402-4546-A3EE-EB6DF3AFFB0A

Q39693472-F0D2EC14-00CC-4761-930D-447A54747849

P304

Q39693472-F7375CE3-4EF0-4AA0-8011-F6F432221C68

P31

Q39693472-274BD0EC-51F3-437F-9792-8A516CF0FE44

P356

Q39693472-472C17E4-7F5D-4C0B-AA87-CC27F8D75FD6

P433

Q39693472-E0EB2AD7-40A2-4478-BA27-8E154235FA1B

P478

Q39693472-6BF427C0-1B86-4235-92BB-87D1C56E7CE9

P577

Q39693472-61840631-57A1-431F-AA86-734535A25260

P698

Q39693472-4351FA6C-6BF7-4AFB-9B78-B94A5C7C2707

P921

Q39693472-6C164A20-2DBA-41B3-B9AA-FD5AD6BE6B53

P356

AJPENDO.00064.2004

P1433

American Journal of Physiology - Endocrinology and Metabolism

P1476

Magnetic resonance spectroscop ...... sis in the general population.

@en

P2093

David Leonard

http://www.w3.org/2001/XMLSchema#string

Helen H Hobbs

http://www.w3.org/2001/XMLSchema#string

Jason S Reingold

http://www.w3.org/2001/XMLSchema#string

Jeffrey D Browning

http://www.w3.org/2001/XMLSchema#string

Lidia S Szczepaniak

http://www.w3.org/2001/XMLSchema#string

Pamela Nurenberg

http://www.w3.org/2001/XMLSchema#string

Robert L Dobbins

http://www.w3.org/2001/XMLSchema#string

Scott Grundy

http://www.w3.org/2001/XMLSchema#string

P304

E462-8

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1152/AJPENDO.00064.2004

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

288

http://www.w3.org/2001/XMLSchema#string

P577

2004-08-31T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

15339742

http://www.w3.org/2001/XMLSchema#string

P921